Razelle Kurzrock joined the UC San Diego Moores Cancer Center in 2012 as senior deputy center director for clinical science, with a broad mandate that includes growing and innovating the clinical trials program and heading the new Center for Personalized Cancer Therapy. She also serves as vice chief of the Division of Hematology Oncology at the UC San Diego School of Medicine. Dr. Kurzrock is widely recognized for her work in translational medicine. As a physician-scientist, she brings unique expertise and experience in clinical research, business operations, regulatory operations, financial and budget planning, and administrative oversight. While at the University of Texas M.D. Anderson Cancer Center, she led the creation of a program that enrolled about 1,200 patients on 128 therapies and ranked as one of the world’s largest hypothesis-driven early stage clinical trials. She uses cutting-edge molecular profiling technologies to match patients with novel targeted therapies, reflecting a personalized strategy to optimize cancer treatment.